Table 2. Recovery and matrix effect for clopidogrel, 2-Oxo-CLP and CAMD without DTT.
| Analytes | Concentration (ng/mL) | Recovery | Matrix effect | |||
| (%) | RSD (%) | (%) | RSD(%) | |||
| All the data are presented as mean±SD. 2-Oxo-CLP: 2-oxo-clopidogrel; CAMD: clopidogrel active metabolite derivative; DTT: 1, 4-Dithio-DL-threitol; RSD: relative standard deviation. | ||||||
| Clopidogrel | 0.1 | 101.9±8.3 | 8.1 | 76.7±2.3 | 3.0 | |
| 40 | 81.5±12.0 | 14.7 | 75.8±10.0 | 13.2 | ||
| 2-Oxo-CLP | 1 | 70.2±22.1 | 31.5 | 74.6±9.7 | 13.0 | |
| 40 | 62.4±6.1 | 9.7 | 60.3±0.5 | 0.9 | ||
| CAMD | 1 | 72.2±26.9 | 37.2 | 75.1±9.7 | 12.9 | |
| 80 | 82.4±15.2 | 18.4 | 69.8±2.2 | 3.1 | ||